Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126751912 | 12675191 | 2 | F | 20160802 | 20160829 | 20160823 | 20160831 | EXP | CH-ROCHE-1817983 | ROCHE | 0.00 | F | Y | 0.00000 | 20160831 | CN | CH | CH |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126751912 | 12675191 | 1 | PS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | U | 103705 | SOLUTION FOR INFUSION | |||||||||
| 126751912 | 12675191 | 2 | SS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | U | 103705 | 600 | MG | SOLUTION FOR INFUSION | |||||||
| 126751912 | 12675191 | 3 | SS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | U | 103705 | 600 | MG | SOLUTION FOR INFUSION | |||||||
| 126751912 | 12675191 | 4 | SS | Gazyvaro | OBINUTUZUMAB | 1 | Intravenous (not otherwise specified) | U | 125486 | 1000 | MG | ||||||||
| 126751912 | 12675191 | 5 | C | BENDAMUSTINE | BENDAMUSTINE | 1 | 0 | ||||||||||||
| 126751912 | 12675191 | 6 | C | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | 0 | |||||||||||
| 126751912 | 12675191 | 7 | C | ONCOVIN | VINCRISTINE SULFATE | 1 | Intravenous (not otherwise specified) | 0 | |||||||||||
| 126751912 | 12675191 | 8 | C | PREDNISONE. | PREDNISONE | 1 | Intravenous (not otherwise specified) | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126751912 | 12675191 | 1 | B-cell lymphoma |
| 126751912 | 12675191 | 4 | B-cell lymphoma |
| 126751912 | 12675191 | 5 | B-cell lymphoma |
| 126751912 | 12675191 | 6 | B-cell lymphoma |
| 126751912 | 12675191 | 7 | B-cell lymphoma |
| 126751912 | 12675191 | 8 | B-cell lymphoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126751912 | 12675191 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126751912 | 12675191 | Dyspnoea | |
| 126751912 | 12675191 | Fatigue | |
| 126751912 | 12675191 | Pulmonary embolism |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126751912 | 12675191 | 1 | 20070829 | 20080312 | 0 | |
| 126751912 | 12675191 | 2 | 200806 | 0 | ||
| 126751912 | 12675191 | 3 | 201509 | 201603 | 0 | |
| 126751912 | 12675191 | 4 | 20160704 | 0 | ||
| 126751912 | 12675191 | 6 | 20070829 | 20080312 | 0 | |
| 126751912 | 12675191 | 7 | 20070829 | 20080312 | 0 | |
| 126751912 | 12675191 | 8 | 20070829 | 20080312 | 0 |